The Trump administration has revised the terms of a pilot effort that will allow some drugmakers to offer rebates to certain ...

Ten years ago, the World Health Organization added mycetoma to its official list of neglected tropical diseases. Caused by ...

Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...

Get the inside view of the 2026 J.P. Morgan Healthcare Conference with STAT reporters on the ground. Hear the deals, data, and emerging themes shaping the year ahead, and leave with a clear sense of ...

An FDA advisory panel recommended use of an experimental Replimune treatment for advanced melanoma that the agency has rejected twice ...

Is the FDA taking inconsistent approaches to Duchenne drugs? And how will a new batch of drug executives shake up their ...

In win for RFK Jr., Senate committee sends nominations of Erica Schwartz for CDC director and Sean Kaufman for ASPR to full ...

Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic ...

A group of outside experts convened by the Food and Drug Administration on Thursday voted in favor of Replimune’s experimental treatment for advanced melanoma. In a 10-3 vote, t ...

STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been the ...

An FDA advisory panel concluded clinical data for a Capricor treatment for Duchenne muscular dystrophy did not provide ...

The next 10 years of mycetoma care will determine whether it remains a story of neglect or becomes one of collective action,” ...